Intravenous enoxaparin has been found to increase activated clotting time (ACT) at 5 minutes in patients undergoing percutaneous coronary intervention (PCI), indicating […]
The Extracorporeal Life Support Organization (ELSO) and all of the ELSO worldwide chapters have prepared this document to describe when and how to use extracorporeal membrane oxygenation (ECMO) in COVID-19 patients during this pandemic.
